Vitiligo: interplay between oxidative stress and immune system (Q26824504)

Mitesh Dwivedi

2

1 reference

Mohmmad S. Mansuri

3

1 reference

Amina R. Gani

4

1 reference

Md Ansarullah

5

1 reference

A. V. Ramachandran

6

1 reference

Sarat Dalai

7

1 reference

Rasheedunnisa Begum

8

1 reference

language of work or name

1 reference

April 2013

1 reference

published in

Experimental Dermatology

1 reference

volume

22

1 reference

issue

4

1 reference

page(s)

245-50

1 reference

The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force

cites work

1 reference

Vitiligo: compendium of clinico-epidemiological features

21 January 2018

1 reference

Review of the etiopathomechanism of vitiligo: a convergence theory

21 January 2018

1 reference

Vitiligo: where do we stand?

21 January 2018

1 reference

In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase

21 January 2018

1 reference

Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo

21 January 2018

1 reference

Low Catalase Levels in the Epidermis of Patients with Vitiligo

21 January 2018

1 reference

Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage.

21 January 2018

1 reference

Increased oxidative DNA damage in mononuclear leukocytes in vitiligo

21 January 2018

1 reference

Increased monoamine oxidase A activity in the epidermis of patients with vitiligo

21 January 2018

1 reference

Study on the antioxidant status of vitiligo patients of different age groups in Baroda

21 January 2018

1 reference

A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients

21 January 2018

1 reference

Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid

21 January 2018

1 reference

Superoxide anions, free-radical scavengers, and nitrergic neurotransmission

21 January 2018

1 reference

The Role of Oxidants and Antioxidants in Generalized Vitiligo

21 January 2018

1 reference

Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo

21 January 2018

1 reference

Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo.

21 January 2018

1 reference

Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo

21 January 2018

1 reference

Central role of defective apoptosis in autoimmunity

21 January 2018

1 reference

Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1.

21 January 2018

1 reference

Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells.

21 January 2018

1 reference

A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

21 January 2018

1 reference

Melanocytorrhagy and apoptosis in vitiligo: connecting jigsaw pieces

21 January 2018

1 reference

Physiopathology and genetics of vitiligo

21 January 2018

1 reference

Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo

21 January 2018

1 reference

Elevated serum antimelanocyte antibody level in cerebriform intradermal nevus with vitiligo

21 January 2018

1 reference

Vitiligo autoantibodies are effective against melanoma

21 January 2018

1 reference

The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

21 January 2018

1 reference

Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy

21 January 2018

1 reference

Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.

21 January 2018

1 reference

Apoptosis of melanocytes in vitiligo results from antibody penetration

21 January 2018

1 reference

Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio

21 January 2018

1 reference

HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1

21 January 2018

1 reference

Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients

21 January 2018

1 reference

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site

21 January 2018

1 reference

Autoimmune etiology of generalized vitiligo.

21 January 2018

1 reference

Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.

21 January 2018

1 reference

An immunohistological study of cutaneous lymphocytes in vitiligo.

21 January 2018

1 reference

Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo

21 January 2018

1 reference

Reduced skin homing by functional Treg in vitiligo

21 January 2018

1 reference

Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo

21 January 2018

1 reference

Th17 cells and activated dendritic cells are increased in vitiligo lesions

21 January 2018

1 reference

Cellular mechanisms of IL-17-induced blood-brain barrier disruption

21 January 2018

1 reference

The genetics of generalized vitiligo

21 January 2018

1 reference

The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma

21 January 2018

1 reference

Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.

21 January 2018

1 reference

Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo

21 January 2018

1 reference

Association of catalase T/C exon 9 and glutathione peroxidase codon 200 polymorphisms in relation to their activities and oxidative stress with vitiligo susceptibility in Gujarat population

21 January 2018

1 reference

Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo.

21 January 2018

1 reference

Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population.

21 January 2018

1 reference

Vitiligo: a manifestation of apoptosis?

21 January 2018

1 reference

The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells.

21 January 2018

1 reference

Role of reactive oxygen species (ROS) in apoptosis induction

21 January 2018

1 reference

Vitiligo as an inflammatory skin disorder: a therapeutic perspective

21 January 2018

1 reference

Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin

21 January 2018

1 reference

Free radical theory of autoimmunity

21 January 2018

1 reference

Oxidatively modified autoantigens in autoimmune diseases

21 January 2018

1 reference

4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo

21 January 2018

1 reference

Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo

21 January 2018

1 reference

Koebner's phenomenon in vitiligo: European position paper

21 January 2018

1 reference

Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo

21 January 2018

1 reference

Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) in isolated vitiligo: a genotype-phenotype correlation

21 January 2018

1 reference

New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions

21 January 2018

1 reference

HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in Vitiligo

21 January 2018

1 reference

Vitiligo antibodies are not directed to tyrosinase

21 January 2018

1 reference

7 January 2021

Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin

1 reference

7 January 2021

Defective calcium transport in vitiliginous melanocytes

1 reference

7 January 2021

Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo

1 reference

7 January 2021

The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma

1 reference

7 January 2021

Why tyrosinase for treatment of melanoma

1 reference

7 January 2021

The role of tyrosinase in autoimmune vitiligo

1 reference

7 January 2021

Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study

1 reference

7 January 2021

Immunological pathomechanisms in vitiligo.

1 reference

7 January 2021

Intrinsic and extrinsic pathomechanisms in vitiligo

1 reference

7 January 2021

Genetic Association of the Catalase Gene (CAT) with Vitiligo Susceptibility

1 reference

7 January 2021

Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families

1 reference

7 January 2021

Apoptosis and autoimmunity

1 reference

7 January 2021

Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo

1 reference

7 January 2021

Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay

1 reference

7 January 2021

Serum selenium levels and blood glutathione peroxidase activities in vitiligo

1 reference

7 January 2021

Tyrosinase as an autoantigen in patients with vitiligo

1 reference

7 January 2021

Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)

1 reference

7 January 2021

Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay

1 reference

7 January 2021

Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo

1 reference

7 January 2021

In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo

1 reference

7 January 2021

Increased Sensitivity to Peroxidative Agents as a Possible Pathogenic Factor of Melanocyte Damage in Vitiligo

1 reference

7 January 2021

Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis

1 reference

7 January 2021

Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo

1 reference

7 January 2021

Role of interleukin-17 in the pathogenesis of vitiligo

1 reference

7 January 2021

Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo

1 reference

7 January 2021

Assessment of the immune system in 55 Iranian patients with vitiligo

1 reference

7 January 2021

Antioxidant status of segmental and non-segmental vitiligo

1 reference

7 January 2021

The genetics of generalized vitiligo and associated autoimmune diseases

1 reference

7 January 2021

Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?

1 reference

7 January 2021

The ACE gene I/ D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population

1 reference

7 January 2021

Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris

1 reference

7 January 2021

Successful treatment of oxidative stress in vitiligo

1 reference

7 January 2021

CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis

1 reference

7 January 2021

Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin

1 reference

7 January 2021

A study of blood CD3+, CD4+, and CD8+ T cell levels and CD4+:CD8+ ratio in vitiligo patients

1 reference

7 January 2021